76 related articles for article (PubMed ID: 24122342)
1. The many lives of CTIP2: from AIDS to cancer and cardiac hypertrophy.
Le Douce V; Cherrier T; Riclet R; Rohr O; Schwartz C
J Cell Physiol; 2014 May; 229(5):533-7. PubMed ID: 24122342
[TBL] [Abstract][Full Text] [Related]
2. [CTIP2, a multifunctional protein: cellular physiopathology and therapeutic implications].
Le Douce V; Cherrier T; Riclet R; Rohr O; Schwartz C
Med Sci (Paris); 2014; 30(8-9):797-802. PubMed ID: 25174758
[TBL] [Abstract][Full Text] [Related]
3. CTIP2 is a negative regulator of P-TEFb.
Cherrier T; Le Douce V; Eilebrecht S; Riclet R; Marban C; Dequiedt F; Goumon Y; Paillart JC; Mericskay M; Parlakian A; Bausero P; Abbas W; Herbein G; Kurdistani SK; Grana X; Van Driessche B; Schwartz C; Candolfi E; Benecke AG; Van Lint C; Rohr O
Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12655-60. PubMed ID: 23852730
[TBL] [Abstract][Full Text] [Related]
4. Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing.
Marban C; Suzanne S; Dequiedt F; de Walque S; Redel L; Van Lint C; Aunis D; Rohr O
EMBO J; 2007 Jan; 26(2):412-23. PubMed ID: 17245431
[TBL] [Abstract][Full Text] [Related]
5. HIC1 controls cellular- and HIV-1- gene transcription via interactions with CTIP2 and HMGA1.
Le Douce V; Forouzanfar F; Eilebrecht S; Van Driessche B; Ait-Ammar A; Verdikt R; Kurashige Y; Marban C; Gautier V; Candolfi E; Benecke AG; Van Lint C; Rohr O; Schwartz C
Sci Rep; 2016 Oct; 6():34920. PubMed ID: 27725726
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIV-1 gene transcription by KAP1 in myeloid lineage.
Ait-Ammar A; Bellefroid M; Daouad F; Martinelli V; Van Assche J; Wallet C; Rodari A; De Rovere M; Fahrenkrog B; Schwartz C; Van Lint C; Gautier V; Rohr O
Sci Rep; 2021 Jan; 11(1):2692. PubMed ID: 33514850
[TBL] [Abstract][Full Text] [Related]
7. The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy.
Buitrago M; Lorenz K; Maass AH; Oberdorf-Maass S; Keller U; Schmitteckert EM; Ivashchenko Y; Lohse MJ; Engelhardt S
Nat Med; 2005 Aug; 11(8):837-44. PubMed ID: 16025126
[TBL] [Abstract][Full Text] [Related]
8. Ctip2-mediated Sp6 transcriptional regulation in dental epithelium-derived cells.
Adiningrat A; Tanimura A; Miyoshi K; Yanuaryska RD; Hagita H; Horiguchi T; Noma T
J Med Invest; 2014; 61(1-2):126-36. PubMed ID: 24705758
[TBL] [Abstract][Full Text] [Related]
9. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.
Tomita H; Nazmy M; Kajimoto K; Yehia G; Molina CA; Sadoshima J
Circ Res; 2003 Jul; 93(1):12-22. PubMed ID: 12791704
[TBL] [Abstract][Full Text] [Related]
10. The Fezf2-Ctip2 genetic pathway regulates the fate choice of subcortical projection neurons in the developing cerebral cortex.
Chen B; Wang SS; Hattox AM; Rayburn H; Nelson SB; McConnell SK
Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11382-7. PubMed ID: 18678899
[TBL] [Abstract][Full Text] [Related]
11. The tumor suppressor role of CTCF.
Fiorentino FP; Giordano A
J Cell Physiol; 2012 Feb; 227(2):479-92. PubMed ID: 21465478
[TBL] [Abstract][Full Text] [Related]
12. Tapping the brake on cardiac growth-endogenous repressors of hypertrophic signaling.
Leenders JJ; Pinto YM; Creemers EE
J Mol Cell Cardiol; 2011 Aug; 51(2):156-67. PubMed ID: 21586293
[TBL] [Abstract][Full Text] [Related]
13. Multiple chromatin modifications important for gene expression changes in cardiac hypertrophy.
Bingham AJ; Ooi L; Wood IC
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1138-40. PubMed ID: 17073769
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in cardiac hypertrophy: angels or devils.
Ding SL; Zhou LY; Li PF
Wiley Interdiscip Rev RNA; 2011; 2(1):124-34. PubMed ID: 21956973
[TBL] [Abstract][Full Text] [Related]
15. [Misregulation of P-TEFb activity: pathological consequences].
Muniz L; Kiss T; Egloff S
Med Sci (Paris); 2012 Feb; 28(2):200-5. PubMed ID: 22377309
[TBL] [Abstract][Full Text] [Related]
16. COUP-TF-interacting protein-2 (Ctip2): driving the coupé of sphingolipid biosynthesis in the epidermis.
Bollag WB
J Invest Dermatol; 2013 Mar; 133(3):593-594. PubMed ID: 23399822
[TBL] [Abstract][Full Text] [Related]
17. Minireview: DEK and gene regulation, oncogenesis and AIDS.
Sitwala KV; Mor-Vaknin N; Markovitz DM
Anticancer Res; 2003; 23(3A):2155-8. PubMed ID: 12894590
[TBL] [Abstract][Full Text] [Related]
18. The repressor element 1-silencing transcription factor regulates heart-specific gene expression using multiple chromatin-modifying complexes.
Bingham AJ; Ooi L; Kozera L; White E; Wood IC
Mol Cell Biol; 2007 Jun; 27(11):4082-92. PubMed ID: 17371849
[TBL] [Abstract][Full Text] [Related]
19. CTIP2 and lipid metabolism: regulation in skin development and associated diseases.
Bhattacharya N; Ganguli-Indra G; Indra AK
Expert Rev Proteomics; 2021 Nov; 18(11):1009-1017. PubMed ID: 34739354
[TBL] [Abstract][Full Text] [Related]
20. MTUS1, a gene encoding angiotensin-II type 2 (AT2) receptor-interacting proteins, in health and disease, with special emphasis on its role in carcinogenesis.
Bozgeyik I; Yumrutas O; Bozgeyik E
Gene; 2017 Aug; 626():54-63. PubMed ID: 28499941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
